FDA Submits Proposed Collection of Information for Review and Clearance

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of the The Real Cost Campaign Outcomes Evaluation Study: Cohort 3.